896 related articles for article (PubMed ID: 17109294)
1. The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli.
Johnson KE; Thorpe CM; Sears CL
Clin Infect Dis; 2006 Dec; 43(12):1587-95. PubMed ID: 17109294
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial resistance of Shiga toxin (verotoxin)-producing Escherichia coli O157:H7 and non-O157 strains isolated from humans, cattle, sheep and food in Spain.
Mora A; Blanco JE; Blanco M; Alonso MP; Dhabi G; Echeita A; González EA; Bernárdez MI; Blanco J
Res Microbiol; 2005 Aug; 156(7):793-806. PubMed ID: 15921895
[TBL] [Abstract][Full Text] [Related]
3. Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002.
Brooks JT; Sowers EG; Wells JG; Greene KD; Griffin PM; Hoekstra RM; Strockbine NA
J Infect Dis; 2005 Oct; 192(8):1422-9. PubMed ID: 16170761
[TBL] [Abstract][Full Text] [Related]
4. [The epidemiology of hemolytic uremic syndrome in Argentina. Diagnosis of the etiologic agent, reservoirs and routes of transmission].
Rivas M; Miliwebsky E; Chinen I; Deza N; Leotta GA
Medicina (B Aires); 2006; 66 Suppl 3():27-32. PubMed ID: 17354474
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of O157 versus non-O157 Shiga toxin-producing Escherichia coli infections in Minnesota, 2000-2006.
Hedican EB; Medus C; Besser JM; Juni BA; Koziol B; Taylor C; Smith KE
Clin Infect Dis; 2009 Aug; 49(3):358-64. PubMed ID: 19548834
[TBL] [Abstract][Full Text] [Related]
6. Bacterial genetic determinants of non-O157 STEC outbreaks and hemolytic-uremic syndrome after infection.
Wickham ME; Lupp C; Mascarenhas M; Vazquez A; Coombes BK; Brown NF; Coburn BA; Deng W; Puente JL; Karmali MA; Finlay BB
J Infect Dis; 2006 Sep; 194(6):819-27. PubMed ID: 16941350
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and pathogenicity of Shiga toxin-producing Escherichia coli in beef cattle and their products.
Hussein HS
J Anim Sci; 2007 Mar; 85(13 Suppl):E63-72. PubMed ID: 17060419
[TBL] [Abstract][Full Text] [Related]
8. Non-O157:H7 pathogenic Shiga toxin-producing Escherichia coli: phenotypic and genetic profiling of virulence traits and evidence for clonality.
Schmidt H; Geitz C; Tarr PI; Frosch M; Karch H
J Infect Dis; 1999 Jan; 179(1):115-23. PubMed ID: 9841830
[TBL] [Abstract][Full Text] [Related]
9. Virulence profiles of Shiga toxin 2e-producing Escherichia coli isolated from healthy pig at slaughter.
Zweifel C; Schumacher S; Beutin L; Blanco J; Stephan R
Vet Microbiol; 2006 Oct; 117(2-4):328-32. PubMed ID: 16872761
[TBL] [Abstract][Full Text] [Related]
10. A multiple protocol to improve diagnosis and isolation of Shiga toxin-producing Escherichia coli from human stool specimens.
Shelton DR; Karns JS; Park CH
Diagn Microbiol Infect Dis; 2008 Sep; 62(1):7-10. PubMed ID: 18550318
[TBL] [Abstract][Full Text] [Related]
11. Micro-array for the identification of Shiga toxin-producing Escherichia coli (STEC) seropathotypes associated with Hemorrhagic Colitis and Hemolytic Uremic Syndrome in humans.
Bugarel M; Beutin L; Martin A; Gill A; Fach P
Int J Food Microbiol; 2010 Sep; 142(3):318-29. PubMed ID: 20675003
[TBL] [Abstract][Full Text] [Related]
12. Escherichia coli O157:H7 and non-O157 Shiga toxin-producing E. coli in healthy cattle, sheep and swine herds in Northern Spain.
Oporto B; Esteban JI; Aduriz G; Juste RA; Hurtado A
Zoonoses Public Health; 2008; 55(2):73-81. PubMed ID: 18234025
[TBL] [Abstract][Full Text] [Related]
13. Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study.
Gerber A; Karch H; Allerberger F; Verweyen HM; Zimmerhackl LB
J Infect Dis; 2002 Aug; 186(4):493-500. PubMed ID: 12195376
[TBL] [Abstract][Full Text] [Related]
14. Laboratory-confirmed non-O157 Shiga toxin-producing Escherichia coli--Connecticut, 2000-2005.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Jan; 56(2):29-31. PubMed ID: 17230143
[TBL] [Abstract][Full Text] [Related]
15. Cluster of hemolytic-uremic syndrome caused by Shiga toxin-producing Escherichia coli O26:H11.
Misselwitz J; Karch H; Bielazewska M; John U; Ringelmann F; Rönnefarth G; Patzer L
Pediatr Infect Dis J; 2003 Apr; 22(4):349-54. PubMed ID: 12690276
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to lipopolysaccharide block adherence of Shiga toxin-producing Escherichia coli to human intestinal epithelial (Henle 407) cells.
Paton AW; Voss E; Manning PA; Paton JC
Microb Pathog; 1998 Jan; 24(1):57-63. PubMed ID: 9466947
[TBL] [Abstract][Full Text] [Related]
17. Diarrheagenic E. coli in hospitalized patients: special reference to Shiga-like toxin producing Escherichia coli.
Lanjewar M; De AS; Mathur M
Indian J Pathol Microbiol; 2010; 53(1):75-8. PubMed ID: 20090227
[TBL] [Abstract][Full Text] [Related]
18. Shiga toxin-producing Escherichia coli: an overview.
Gyles CL
J Anim Sci; 2007 Mar; 85(13 Suppl):E45-62. PubMed ID: 17085726
[TBL] [Abstract][Full Text] [Related]
19. Surveillance of hemolytic uremic syndrome in children less than 15 years of age, a system to monitor O157 and non-O157 Shiga toxin-producing Escherichia coli infections in France, 1996-2006.
Espié E; Grimont F; Mariani-Kurkdjian P; Bouvet P; Haeghebaert S; Filliol I; Loirat C; Decludt B; Minh NN; Vaillant V; de Valk H
Pediatr Infect Dis J; 2008 Jul; 27(7):595-601. PubMed ID: 18520972
[TBL] [Abstract][Full Text] [Related]
20. [Enterohemorrhagic Escherichia coli and its infection: from 1977 to 1995].
Takede Y
Nihon Rinsho; 1997 Mar; 55(3):635-40. PubMed ID: 9086772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
